Utah Medical Products | UTMD - Equity Capital And Reserves


Utah Medical Products reported $119.27M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AngioDynamics USD 176.33M 2.52M Sep/2025
Baxter International USD 6.04B 86M Mar/2026
Cerus USD 64.22M 2.76M Dec/2025
CONMED USD 1.02B 15.42M Mar/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
General Electric Aerospace USD 18.06B 841M Mar/2026
Integra LifeSciences USD 1.04B 1.06M Mar/2026
J&J USD 81.19B 358M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.63B 42.42M Mar/2026
OraSure Technologies USD 313.32M 27.5M Mar/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 352.37M 8.18M Mar/2026
Stryker USD 22.42B 635M Dec/2025
Teleflex USD 3.08B 40.33M Mar/2026
Utah Medical Products USD 119.27M 1.02M Dec/2025
West Pharmaceutical Services USD 2.99B 185.6M Mar/2026